Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration date novartis gsk composition matter?Mebendazole ingredients?How long have hydroxyzine pamoate been on the market?Patent expiry trametinib?Pramlintide acetate price?
See the DrugPatentWatch profile for Zavzpret
Zavzpret (zavegepant) received FDA approval on December 12, 2023.[1]
The FDA approved Zavzpret for the acute treatment of migraine in adults.[2]
You can cross-check the approval timing on DrugPatentWatch.com, which tracks FDA-approval and related regulatory milestones.[1]
1 2
Other Questions About Zavzpret :